Cotinga Pharmaceuticals P/E
What is the P/E of Cotinga Pharmaceuticals?
The P/E of Cotinga Pharmaceuticals, Inc. is N/A
What is the definition of P/E?
Price to earnings ratio is the ratio of a company’s stock price to the company’s earnings per share calculated over trailing twelve months.
= previous day’s close / ttm EPS
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E of companies in the Health Care sector on TSXV compared to Cotinga Pharmaceuticals
What does Cotinga Pharmaceuticals do?
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Companies with p/e similar to Cotinga Pharmaceuticals
- InvoCare has P/E of N/A
- Argen X SE has P/E of N/A
- Indiabulls Ventures has P/E of N/A
- Kokuyo Camlin has P/E of N/A
- Hong Kong Television Network has P/E of N/A
- Biocorp Production has P/E of N/A
- Cotinga Pharmaceuticals has P/E of N/A
- Tailam Tech Constr Hldg Ltd has P/E of N/A
- MPC Münchmeyer Petersen Capital AG has P/E of N/A
- MAG Silver has P/E of N/A
- Hays plc has P/E of N/A
- Two Shields Investments Plc has P/E of N/A
- MAG Silver has P/E of N/A